Place of Origin : Nanjing,China
Delivery Terms : With Customers Request
Delivery Time : As Customer Required
Product Capacity : 100Kilogram/Month
Payment Terms : L/C,T/T,Western Union,MoneyGram
Classification: Pharmaceutical
Cas NO.: 763113-22-0
Molecular Formula: C24H23FN4O3
Olaparib (AZD-2281, trade name Lynparza) is an FDA-approved targeted therapy for cancer, developed by scientists at the University of Sheffield, KuDOS Pharmaceuticals and later by AstraZeneca. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair.
Classification: Pharmaceutical
Cas NO.: 763113-22-0
Molecular Formula: C24H23FN4O3
Olaparib (AZD-2281, Trade Name Lynparza) Is An FDA-approved Targeted Therapy For Cancer, Developed By Scientists At The University Of Sheffield, KuDOS Pharmaceuticals And Later By AstraZeneca. It Is A PARP Inhibitor, Inhibiting Poly ADP Ribose Polymerase (PARP), An Enzyme Involved In DNA Repair.
